Metraipolis › archive › dc_c98977587f3c

A case report on the treatment of autoimmune hemolytic anemia after CBT by daratumumab in a mucopolysaccharidosis type III patient — Europe PMC PMID:41029071

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41029071
DOI
10.1097/md.0000000000044874
License (as archived)
solo-consultazione
Archived
2026-11-10T05:50:24.499Z
SHA-256 of the archived text
985f270f1a2700f2085492e095745067eb3d4b3814b02b126b85bd1ff577aba1
Stable URL of this page
https://metraipolis.com/documento/dc_c98977587f3c

How to cite

A case report on the treatment of autoimmune hemolytic anemia after CBT by daratumumab in a mucopolysaccharidosis type III patient — Europe PMC PMID:41029071 — Europe PMC (en), https://europepmc.org/article/MED/41029071 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c98977587f3c (Metraipolis archive dc_c98977587f3c, sha256 985f270f1a2700f2085492e095745067eb3d4b3814b02b126b85bd1ff577aba1)
BibTeX
@misc{dcc98977587f3c,
  title = {A case report on the treatment of autoimmune hemolytic anemia after CBT by daratumumab in a mucopolysaccharidosis type III patient — Europe PMC PMID:41029071},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41029071},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c98977587f3c; sha256 985f270f1a2700f2085492e095745067eb3d4b3814b02b126b85bd1ff577aba1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41029071. Agents can read the archived copy with the MCP tool read_document.